Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Adiposity indicators and dementia over 32 years in Sweden.

Gustafson DR, Bäckman K, Waern M, Ostling S, Guo X, Zandi P, Mielke MM, Bengtsson C, Skoog I.

Neurology. 2009 Nov 10;73(19):1559-66. doi: 10.1212/WNL.0b013e3181c0d4b6.

2.

Olfactory impairment in presymptomatic Alzheimer's disease.

Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA.

Ann N Y Acad Sci. 2009 Jul;1170:730-5. doi: 10.1111/j.1749-6632.2009.04013.x.

3.

Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.

Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA.

Dement Geriatr Cogn Disord. 2009;28(1):75-80. doi: 10.1159/000231980. Epub 2009 Aug 4.

4.

Change in blood pressure and incident dementia: a 32-year prospective study.

Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ.

Hypertension. 2009 Aug;54(2):233-40. doi: 10.1161/HYPERTENSIONAHA.109.128744. Epub 2009 Jun 29.

5.

Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.

Geda YE, Roberts RO, Knopman DS, Petersen RC, Christianson TJ, Pankratz VS, Smith GE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA.

Arch Gen Psychiatry. 2008 Oct;65(10):1193-8. doi: 10.1001/archpsyc.65.10.1193.

6.

Brain circuits regulating energy homeostasis.

Abizaid A, Horvath TL.

Regul Pept. 2008 Aug 7;149(1-3):3-10. doi: 10.1016/j.regpep.2007.10.006. Epub 2008 Mar 25. Review.

7.

Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis.

Anstey KJ, Lipnicki DM, Low LF.

Am J Geriatr Psychiatry. 2008 May;16(5):343-54. doi: 10.1097/JGP.0b013e31816b72d4.

PMID:
18448847
8.

Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

Stewart R, White LR, Xue QL, Launer LJ.

Arch Neurol. 2007 Jan;64(1):103-7.

PMID:
17210816
9.

Midlife respiratory function and Incidence of Alzheimer's disease: a 29-year longitudinal study in women.

Guo X, Waern M, Sjögren K, Lissner L, Bengtsson C, Björkelund C, Ostling S, Gustafson D, Skoog I.

Neurobiol Aging. 2007 Mar;28(3):343-50. Epub 2006 Mar 2.

PMID:
16513221
10.

Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.

Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2005 Oct 11;65(7):1045-50.

PMID:
16217057
11.

High total cholesterol levels in late life associated with a reduced risk of dementia.

Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B, Skoog I.

Neurology. 2005 May 24;64(10):1689-95.

PMID:
15911792
12.

Midlife cardiovascular risk factors and risk of dementia in late life.

Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K.

Neurology. 2005 Jan 25;64(2):277-81.

PMID:
15668425
13.

The epidemiologic study of dementia: a life-long quest?

Launer LJ.

Neurobiol Aging. 2005 Mar;26(3):335-40. Review.

PMID:
15639311
14.

Relation of plasma lipids to Alzheimer disease and vascular dementia.

Reitz C, Tang MX, Luchsinger J, Mayeux R.

Arch Neurol. 2004 May;61(5):705-14.

15.

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.

Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM.

Neurology. 2003 Jul 22;61(2):199-205.

PMID:
12874399
16.

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA.

Arch Intern Med. 2003 May 12;163(9):1053-7.

PMID:
12742802
17.

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H.

Ann Intern Med. 2002 Aug 6;137(3):149-55.

PMID:
12160362
18.

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE.

Neurobiol Dis. 2001 Oct;8(5):890-9.

PMID:
11592856
19.

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5856-61. Epub 2001 Apr 10.

20.

Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study.

Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2255-60.

Supplemental Content

Support Center